Qiran Wei

2PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 15, 2025
HRR deficiency-guided use of talazoparib plus enzalutamide in patients with metastatic castration-resistant prostate cancer: a cost-effectiveness analysis.

Mingjun Rui, Yingcheng Wang, Qiran Wei

|Nov 18, 2024
Cost-Effectiveness Analysis of Adjuvant Alectinib versus Platinum-Based Chemotherapy in Resected ALK-Positive Non-Small-Cell Lung Cancer in the Chinese Health Care System.

Qiran Wei, Yifang Liang, Jiahui Mao

Pageof 1

Frequent Collaborators

1 joint publications

Mingjun Rui

1 joint publications

Yingcheng Wang

1 joint publications

Joyce H S You